05.05.16
Embria Health Sciences has expanded the market for its fermented immune supplement ingredient EpiCor into Central and Eastern Europe with a new distribution agreement with Hermes Consilium, d.o.o. Through this agreement Hermes Consilium will be the exclusive sales agent for EpiCor within 10 countries—Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Slovenia, Croatia, Serbia and Macedonia.
Blaž Gorjup, managing director of Hermes Consilium, said, “Hermes Consilium deals exclusively with high-quality, science-based specialty ingredients and EpiCor aligns perfectly with our business approach. EpiCor will be a great addition to our ingredient portfolio by helping us to expand into the immune, digestive and overall wellness product categories with a scientifically-proven ingredient.”
Jeff Cannon, CEO of Embria’s parent company Diamond V, commented, “Embria continues to expand internationally and we have seen sales continue to grow exponentially overseas. People worldwide are looking for the unique health benefits that natural, well-researched ingredients like EpiCor provide. We are excited to enter Central and Eastern Europe and enable over 100 million people to supplement their everyday health with EpiCor.”
For more information: www.embriahealth.com
Blaž Gorjup, managing director of Hermes Consilium, said, “Hermes Consilium deals exclusively with high-quality, science-based specialty ingredients and EpiCor aligns perfectly with our business approach. EpiCor will be a great addition to our ingredient portfolio by helping us to expand into the immune, digestive and overall wellness product categories with a scientifically-proven ingredient.”
Jeff Cannon, CEO of Embria’s parent company Diamond V, commented, “Embria continues to expand internationally and we have seen sales continue to grow exponentially overseas. People worldwide are looking for the unique health benefits that natural, well-researched ingredients like EpiCor provide. We are excited to enter Central and Eastern Europe and enable over 100 million people to supplement their everyday health with EpiCor.”
For more information: www.embriahealth.com
